Impact of metabolic syndrome on the incidence of type 2 diabetes in middle-aged Japanese individuals with impaired insulin secretion: the Saku study

被引:0
作者
Morimoto A. [1 ]
Tatsumi Y. [2 ]
Sonoda N. [3 ]
Miyamatsu N. [1 ]
Shimoda T. [4 ]
Sakaguchi S. [4 ]
机构
[1] Department of Clinical Nursing, Shiga University of Medical Science, Tsukinowa-cho Seta, Otsu, 520-2192, Shiga
[2] Department of Hygiene and Public Health, Teikyo University, 2-11-1 Kaga, Itabashi-Ku, 173-8605, Tokyo
[3] Department of Mathematical Health Science, Graduate School of Medicine, Osaka University, 1-7 Yamadaoka, Suita, 565-0871, Osaka
[4] Saku Central Hospital, 197 Usuda, Saku, 384-0301, Nagano
基金
日本学术振兴会;
关键词
Impaired insulin secretion; Metabolic syndrome; Middle age; Type; 2; diabetes;
D O I
10.1007/s13340-016-0287-6
中图分类号
学科分类号
摘要
Aims: To assess the impact of metabolic syndrome (MetS) on the incidence of type 2 diabetes in middle-aged Japanese individuals with impaired insulin secretion (IIS). Methods: This cohort study included 1,702 individuals aged 40–59 without diabetes at baseline who underwent a comprehensive medical check-up between April 2008 and March 2009 at Saku Central Hospital. Participants were classified according to their IIS and insulin resistance (IR) status [normal, isolated IR (i-IR), or isolated IIS (i-IIS)] and MetS (presence or absence). They were followed up until March 2014. Type 2 diabetes was defined based on fasting and 2-h post-load plasma glucose concentrations and by the receipt of medical treatment for diabetes. Results: During 7,572 person-years of follow-up, 92 individuals developed type 2 diabetes. The incidence rates (/1,000 person-years) for type 2 diabetes in the normal without MetS, normal with MetS, i-IR without MetS, i-IR with MetS, i-IIS without MetS, and i-IIS with MetS groups were 5.3, 3.7, 11.3, 24.7, 16.7, and 59.5, respectively. The multivariable-adjusted hazard ratios (HRs) and 95 % confidence intervals (CIs) for type 2 diabetes in the normal with MetS, i-IR with MetS, and i-IIS with MetS groups, relative to the normal without MetS group, were 0.52 (0.12–2.25), 3.78 (1.93–7.42), and 7.94 (3.96–15.91), respectively. Additionally, a positive association of MetS with type 2 diabetes was observed in the i-IIS group [HR (95 % CI) 3.56 (1.88–6.73)] but not in the normal and i-IR groups. Conclusions: The prevention of MetS is important, particularly in individuals with low insulin secretion. © 2016, The Japan Diabetes Society.
引用
收藏
页码:104 / 111
页数:7
相关论文
共 33 条
  • [1] Danaei G., Finucane M.M., Lu Y., Singh G.M., Cowan M.J., Paciorek C.J., Et al., National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants, Lancet, 378, pp. 31-40, (2011)
  • [2] Wild S., Roglic G., Green A., Sicree R., King G., Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030, Diabet Care, 27, pp. 1047-1053, (2004)
  • [3] Guariguata L., Whiting D.R., Hambleton I., Beagley J., Linnenkamp U., Shaw J.E., Global estimates of diabetes prevalence for 2013 and projections for 2035, Diabet Res Clin Pract, 103, pp. 137-149, (2014)
  • [4] Kahn S.E., The relative contribution of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes, Diabetologia, 46, pp. 3-19, (2003)
  • [5] Martin B.C., Warram J.H., Krolewski A.S., Bergman R.N., Soeldner J.S., Kahn C.R., Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study, Lancet, 340, pp. 925-929, (1992)
  • [6] Kodama K., Tojjar D., Yamada S., Toda K., Patel C.J., Butte A.J., Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis, Diabet Care, 36, pp. 1789-1796, (2013)
  • [7] Ahuja V., Kadowaki T., Evans R.W., Kadota A., Okamura T., El Khoudary S.R., Et al., Comparison of HOMA-IR, HOMA-β% and disposition index between US white men and Japanese men in Japan: the ERA JUMP study, Diabetologia, 58, pp. 265-271, (2015)
  • [8] Yabe D., Seino Y., Fukushima M., Seino S., β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians, Curr Diabet Rep, 15, (2015)
  • [9] Morimoto A., Tatsumi Y., Deura K., Mizuno S., Ohno Y., Miyamatsu N., Et al., Impact of impaired insulin secretion and insulin resistance on the incidence of type 2 diabetes mellitus in a Japanese population: the Saku study, Diabetologia, 56, pp. 1671-1679, (2013)
  • [10] Chan J.C., Malik V., Jia W., Kadowaki T., Yajnik C.S., Yoon K.H., Et al., Diabetes in Asia: epidemiology, risk factors, and pathophysiology, JAMA, 301, pp. 2129-2140, (2009)